A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension.

RATIONALE Females are predisposed to pulmonary arterial hypertension (PAH); evidence suggests that serotonin, mutations in the bone morphogenetic protein receptor (BMPR) II gene, and estrogens influence development of PAH. The 5-hydroxytryptamine 1B receptor (5-HT1BR) mediates human pulmonary artery smooth muscle cell (hPASMC) proliferation. OBJECTIVES We aimed to determine whether selected microRNAs (miRNAs) expressed in PASMCs are influenced by sex, BMPR-II mutations, and estrogens, and contribute to PASMC proliferation in PAH. METHODS Expression levels of miRNAs targeting genes related to PAH, estrogen, and serotonin were determined by quantitative RT-PCR in hPASMCs and mouse PASMCs harboring a heterozygous mutation in BMPR-II (BMPR-II(R899X+/-) PASMCs). miRNA-96 targets 5-HT1BR and was selected for further investigation. miRNA target validation was confirmed by luciferase reporter assay. Precursor miRNA-96 was transfected into hPASMCs to examine effects on proliferation and 5-HT1BR expression. The effect of a miRNA-96 mimic on the development of hypoxic pulmonary hypertension in mice was also assessed. MEASUREMENTS AND MAIN RESULTS miRNA-96 expression was reduced in BMPR-II(R899X+/-) PASMCs from female mice and hPASMCs from female patients with PAH; this was associated with increased 5-HT1BR expression and serotonin-mediated proliferation. 5-HT1BR was validated as a target for miRNA-96. Transfection of precursor miRNA-96 into hPASMCs reduced 5-HT1BR expression and inhibited serotonin-induced proliferation. Restoration of miRNA-96 expression in pulmonary arteries in vivo via administration of an miRNA-96 mimic reduced the development of hypoxia-induced pulmonary hypertension in the mouse. CONCLUSIONS Increased 5-HT1BR expression may be a consequence of decreased miRNA-96 expression in female patient PASMCs, and this may contribute to the development of PAH.

[1]  N. Morrell,et al.  Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells. , 2015, American journal of respiratory and critical care medicine.

[2]  D. Rowlands,et al.  Sex-dependent influence of endogenous estrogen in pulmonary hypertension. , 2014, American journal of respiratory and critical care medicine.

[3]  A. Bjartell,et al.  Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1 , 2013, PloS one.

[4]  D. Bernstein,et al.  FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension. , 2013, The Journal of clinical investigation.

[5]  T. Logvinenko,et al.  miRNA regulated pathways in late stage murine lung development , 2013, BMC Developmental Biology.

[6]  I. Morecroft,et al.  Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension , 2013, Cardiovascular research.

[7]  Y. Deshaies,et al.  Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology , 2013, Journal of the American Heart Association.

[8]  M. Hamon,et al.  Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[9]  J. McClure,et al.  Activity of the Estrogen-Metabolizing Enzyme Cytochrome P450 1B1 Influences the Development of Pulmonary Arterial Hypertension , 2012, Circulation.

[10]  E. Olson,et al.  A Role for miR-145 in Pulmonary Arterial Hypertension: Evidence From Mouse Models and Patient Samples , 2012, Circulation research.

[11]  John A. Phillips III,et al.  BMPR2 expression is suppressed by signaling through the estrogen receptor , 2012, Biology of Sex Differences.

[12]  N. Ambartsumian,et al.  Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females , 2011, Respiratory research.

[13]  N. Morrell,et al.  S97 BMPR2 R899X knock-in mice developed age-related pulmonary hypertension , 2011, Thorax.

[14]  David A. Simpson,et al.  MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia , 2011, Molecular and Cellular Biology.

[15]  Satoru Takahashi,et al.  Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer , 2011, Breast Cancer Research and Treatment.

[16]  M. Nilsen,et al.  The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. , 2011, Cardiovascular research.

[17]  J. McClure,et al.  Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. , 2011, Physiological genomics.

[18]  Libing Song,et al.  Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.

[19]  J. Launay,et al.  MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants , 2010, Science.

[20]  Jia Yu,et al.  miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. , 2010, Cancer research.

[21]  C. Croce,et al.  MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. , 2010, Journal of the National Cancer Institute.

[22]  R. Khanin,et al.  Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and Monocrotaline , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[23]  I. Morecroft,et al.  In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension. , 2010, Cardiovascular research.

[24]  G. Hannon,et al.  The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response , 2009, Proceedings of the National Academy of Sciences.

[25]  E. Barillot,et al.  Highly Dynamic and Sex-Specific Expression of microRNAs During Early ES Cell Differentiation , 2009, PLoS genetics.

[26]  T. Conner,et al.  A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors , 2009, Molecular Psychiatry.

[27]  N. Morrell,et al.  Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease , 2009, Circulation.

[28]  M. Zavolan,et al.  miRNA in situ hybridization in formaldehyde and EDC–fixed tissues , 2009, Nature Methods.

[29]  T. Palmer,et al.  Novel interactions between the 5‐HT transporter, 5‐HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts , 2008, British journal of pharmacology.

[30]  I. Morecroft,et al.  Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-Induced Pulmonary Hypertension , 2007, Hypertension.

[31]  M. Humbert,et al.  Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. , 2006, Circulation.

[32]  Shingo Takagi,et al.  MicroRNA regulates the expression of human cytochrome P450 1B1. , 2006, Cancer research.

[33]  N. Rudarakanchana,et al.  Serotonin Increases Susceptibility to Pulmonary Hypertension in BMPR2-Deficient Mice , 2006, Circulation research.

[34]  A. Harmar,et al.  Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease , 2005, Circulation research.

[35]  N. Rudarakanchana,et al.  Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension , 2005, Circulation research.

[36]  A. Harmar,et al.  Functional Interactions between 5-Hydroxytryptamine Receptors and the Serotonin Transporter in Pulmonary Arteries , 2005, Journal of Pharmacology and Experimental Therapeutics.

[37]  Yuichiro J Suzuki,et al.  Rho Kinase–Induced Nuclear Translocation of ERK1/ERK2 in Smooth Muscle Cell Mitogenesis Caused by Serotonin , 2004, Circulation research.

[38]  M. Humbert,et al.  Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension , 2004, Circulation research.

[39]  M. Maclean,et al.  Contribution of the 5-HT1B Receptor to Hypoxia-Induced Pulmonary Hypertension: Converging Evidence Using 5-HT1B-Receptor Knockout Mice and the 5-HT1B/1D-Receptor Antagonist GR127935 , 2001, Circulation research.

[40]  M. Maclean,et al.  Increased contractile response to 5‐hydroxytryptamine1‐receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy , 2001, British journal of pharmacology.

[41]  M. Maclean.  Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action? , 1999, Trends in pharmacological sciences.

[42]  M. Maclean,et al.  5‐hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5‐HT1B receptor , 1999, British journal of pharmacology.

[43]  J. Dickenson,et al.  Human 5-HT1B receptor stimulated inositol phospholipid hydrolysis in CHO cells: synergy with Gq-coupled receptors. , 1998, European journal of pharmacology.

[44]  J. Dickenson,et al.  Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells. , 1996, European journal of pharmacology.

[45]  M. Maclean,et al.  Contractile Responses to Sumatriptan in Isolated Bovine Pulmonary Artery Rings: Relationship to Tone and Cyclic Nucleotide Levels , 1995, Journal of cardiovascular pharmacology.

[46]  M. Kay,et al.  Regulation of miRNA-mediated gene silencing by miRNA precursors , 2014, Nature Structural &Molecular Biology.

[47]  M. Humbert,et al.  Pulmonary arterial hypertension: epidemiology and registries. , 2013, Journal of the American College of Cardiology.

[48]  H. Palevsky,et al.  Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. , 2012, Chest.

[49]  A. Hata,et al.  SMAD proteins control DROSHA-mediated microRNA maturation , 2008, Nature.

[50]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[51]  M. Yacoub,et al.  ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. , 2002, American journal of respiratory and critical care medicine.